" class="no-js "lang="en-US"> AdBio partners Archives - Medtech Alert
Wednesday, April 10, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Thabor Therapeutics Appoints Jérémie Mariau as Ceo

Thabor Therapeutics, a company developing an innovative treatment for patients living with chronic mucosal inflammatory […]

AdBio Partners Welcomes Inserm Transfert As Investor in Second Fund – AFB Fund II

AdBio partners, an AMF-regulated (the French financial market authority) investment company dedicated to life sciences, […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more